Aptose enters equity distribution agreement with Piper Sandler and Canaccord Genuity

Date Closed

May 05, 2020

Lead Office

Québec City


75.00 Million USD

On May 5, 2020, Aptose Biosciences Inc. finalized its equity distribution agreement with Piper Sandler and Canaccord Genuity, acting as co-agents, to sell at-the-market offerings on the Nasdaq for Aptose. The common share offering will be by way of prospectus supplement and would have an aggregate offering price of up to US$75 million.

Aptose, headquartered in Toronto, Ontario, is a biopharmaceutical company. It focuses on the discovery, research and development of anti-cancer therapies.

McCarthy Tetrault advised Aptose with a team led by Charles-Antoine Soulière that included Myreille Gilbert, David Martin, and Annie Poirier-Simard.